Page last updated: 2024-08-24

emitefur and Adenocarcinoma

emitefur has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asakawa, M; Fujii, M; Fukuoka, M; Furuse, K; Nakai, Y; Niitani, H; Ohta, M; Yamaguchi, Y; Yoshida, K1
Ichihara, N; Imaoka, T; Miyauchi, S; Motoyama, M1

Trials

1 trial(s) available for emitefur and Adenocarcinoma

ArticleYear
Efficacy of a new 5-fluorouracil derivative, BOF-A2, in advanced non-small cell lung cancer. A multi-center phase II study.
    Acta oncologica (Stockholm, Sweden), 1994, Volume: 33, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Anemia; Antineoplastic Agents; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vomiting

1994

Other Studies

1 other study(ies) available for emitefur and Adenocarcinoma

ArticleYear
[Effect of BOF-A2 on experimental and spontaneous metastasis model of mouse colon 26].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1994, Volume: 21, Issue:8

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Body Weight; Chemotherapy, Adjuvant; Colonic Neoplasms; Fluorouracil; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation

1994